The challenge of targeting cancer stem cells to halt metastasis.
暂无分享,去创建一个
C. Box | A. Calvo | A. Agliano
[1] Patrick Soon-Shiong,et al. Molecular heterogeneity in breast cancer: State of the science and implications for patient care. , 2017, Seminars in cell & developmental biology.
[2] Y. Einaga,et al. Dose-escalation study for the targeting of CD44v+ cancer stem cells by sulfasalazine in patients with advanced gastric cancer (EPOC1205) , 2017, Gastric Cancer.
[3] M. Griswold,et al. Analysis of Chemopredictive Assay for Targeting Cancer Stem Cells in Glioblastoma Patients , 2017, Translational oncology.
[4] W. Walters,et al. Curcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species , 2017, BMC Cancer.
[5] Dhiraj Kumar,et al. Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma , 2017, Molecular Cancer.
[6] T. Bekaii-Saab,et al. Identifying and targeting cancer stem cells in the treatment of gastric cancer , 2017, Cancer.
[7] R. Khokha,et al. MiR-26a inhibits stem cell-like phenotype and tumor growth of osteosarcoma by targeting Jagged1 , 2017, Oncogene.
[8] K. Chan,et al. Integrin α7 is a functional cancer stem cell surface marker in oesophageal squamous cell carcinoma , 2016, Nature Communications.
[9] Alexey P. Porfirev,et al. Polarization conversion when focusing cylindrically polarized vortex beams , 2016, Scientific Reports.
[10] Wei Zhao,et al. Targeting Strategies for Renal Cell Carcinoma: From Renal Cancer Cells to Renal Cancer Stem Cells , 2016, Front. Pharmacol..
[11] Deric M. Park,et al. Phase I study of RO4929097 with bevacizumab in patients with recurrent malignant glioma , 2016, Journal of Neuro-Oncology.
[12] W. Fan,et al. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics , 2016, Molecular medicine reports.
[13] S. Gollin,et al. Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas. , 2016, Experimental cell research.
[14] Xiaoyuan Song,et al. Hepatocellular Carcinoma-propagating Cells are Detectable by Side Population Analysis and Possess an Expression Profile Reflective of a Primitive Origin , 2016, Scientific Reports.
[15] K. Okkenhaug,et al. Targeting PI3K in Cancer: Impact on Tumor Cells, Their Protective Stroma, Angiogenesis, and Immunotherapy. , 2016, Cancer discovery.
[16] Steven J. Greco,et al. Mesenchymal Stem Cell-Derived Exosomes Stimulate Cycling Quiescence and Early Breast Cancer Dormancy in Bone Marrow. , 2016, Cancer research.
[17] Jie Gao,et al. Codelivery of salinomycin and doxorubicin using nanoliposomes for targeting both liver cancer cells and cancer stem cells. , 2016, Nanomedicine.
[18] Koji Okamoto,et al. TNIK inhibition abrogates colorectal cancer stemness , 2016, Nature Communications.
[19] E. Hurt,et al. Therapeutic Efficacy of Cancer Stem Cell Vaccines in the Adjuvant Setting. , 2016, Cancer research.
[20] X. Shao,et al. NUMB negatively regulates the epithelial-mesenchymal transition of triple-negative breast cancer by antagonizing Notch signaling , 2016, Oncotarget.
[21] S. Gurunathan,et al. Combination of salinomycin and silver nanoparticles enhances apoptosis and autophagy in human ovarian cancer cells: an effective anticancer therapy , 2016, International journal of nanomedicine.
[22] G. Semenza,et al. PHGDH Expression Is Required for Mitochondrial Redox Homeostasis, Breast Cancer Stem Cell Maintenance, and Lung Metastasis. , 2016, Cancer research.
[23] A. Brandes,et al. A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma. , 2016, Neuro-oncology.
[24] Su In Lee,et al. Hypoxia-NOTCH1-SOX2 signaling is important for maintaining cancer stem cells in ovarian cancer , 2016, Oncotarget.
[25] S. Dong,et al. An iTEP-salinomycin nanoparticle that specifically and effectively inhibits metastases of 4T1 orthotopic breast tumors. , 2016, Biomaterials.
[26] G. Kibria,et al. miR-206 Inhibits Stemness and Metastasis of Breast Cancer by Targeting MKL1/IL11 Pathway , 2016, Clinical Cancer Research.
[27] M. Mi,et al. 3,6-dihydroxyflavone suppresses the epithelial-mesenchymal transition in breast cancer cells by inhibiting the Notch signaling pathway , 2016, Scientific Reports.
[28] S. Takao,et al. Efficient elimination of pancreatic cancer stem cells by hedgehog/GLI inhibitor GANT61 in combination with mTOR inhibition , 2016, Molecular Cancer.
[29] Jacques Haiech,et al. Cancer Stem Cell Quiescence and Plasticity as Major Challenges in Cancer Therapy , 2016, Stem cells international.
[30] E. Rofstad,et al. Cancer stem cells (CSCs), cervical CSCs and targeted therapies , 2016, Oncotarget.
[31] Xiaolong Wang,et al. Hedgehog pathway is involved in nitidine chloride induced inhibition of epithelial-mesenchymal transition and cancer stem cells-like properties in breast cancer cells , 2016, Cell & Bioscience.
[32] J. Dick,et al. miRNA-126 Orchestrates an Oncogenic Program in B Cell Precursor Acute Lymphoblastic Leukemia. , 2016, Cancer cell.
[33] J. Guan,et al. Autophagy Differentially Regulates Distinct Breast Cancer Stem-like Cells in Murine Models via EGFR/Stat3 and Tgfβ/Smad Signaling. , 2016, Cancer research.
[34] Guoping Zhao,et al. CD44hiCD24lo mammosphere-forming cells from primary breast cancer display resistance to multiple chemotherapeutic drugs. , 2016, Oncology reports.
[35] L. Hood,et al. TGFβ‐Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme , 2016, Stem cells.
[36] F. Sotgia,et al. Cancer stem cell metabolism , 2016, Breast Cancer Research.
[37] W. Edenfield,et al. A Phase Ib/II Study of Cancer Stemness Inhibitor Napabucasin (BB608) Combined with Weekly Paclitaxel in Advanced Triple Negative Breast Cancer. , 2016 .
[38] F. Marcucci,et al. Anti-Cancer Stem-like Cell Compounds in Clinical Development – An Overview and Critical Appraisal , 2016, Front. Oncol..
[39] F. Verhaegen,et al. NOTCH blockade combined with radiation therapy and temozolomide prolongs survival of orthotopic glioblastoma , 2016, Oncotarget.
[40] K. Peck,et al. Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial , 2016, Clinical Cancer Research.
[41] S. Do,et al. Notch1 signaling contributes to stemness in head and neck squamous cell carcinoma , 2016, Laboratory Investigation.
[42] J. Meléndez-Zajgla,et al. miR‐10b expression in breast cancer stem cells supports self‐renewal through negative PTEN regulation and sustained AKT activation , 2016, EMBO reports.
[43] F. Sotgia,et al. Repurposing atovaquone: Targeting mitochondrial complex III and OXPHOS to eradicate cancer stem cells , 2016, Oncotarget.
[44] R. Majeti,et al. SIRPα-Antibody Fusion Proteins Selectively Bind and Eliminate Dual Antigen-Expressing Tumor Cells , 2016, Clinical Cancer Research.
[45] P. Theodoropoulos,et al. Stem cell technology in breast cancer: current status and potential applications , 2016, Stem cells and cloning : advances and applications.
[46] A. Kulkarni,et al. NOTCH1 inhibition enhances the efficacy of conventional chemotherapeutic agents by targeting head neck cancer stem cell , 2016, Scientific Reports.
[47] X. Yang,et al. Gastric Lgr5+ stem cells are the cellular origin of invasive intestinal-type gastric cancer in mice , 2016, Cell Research.
[48] Xin Chen,et al. Defining a Population of Stem-like Human Prostate Cancer Cells That Can Generate and Propagate Castration-Resistant Prostate Cancer , 2016, Clinical Cancer Research.
[49] A. Carnero,et al. The hypoxic microenvironment: A determinant of cancer stem cell evolution , 2016, BioEssays : news and reviews in molecular, cellular and developmental biology.
[50] Aaron M. Newman,et al. Identification of tumorigenic cells and therapeutic targets in pancreatic neuroendocrine tumors , 2016, Proceedings of the National Academy of Sciences.
[51] K. O'Byrne,et al. Lung cancer stem cells: The root of resistance. , 2016, Cancer letters.
[52] Elisa de Stanchina,et al. Metastatic Latency and Immune Evasion through Autocrine Inhibition of WNT , 2016, Cell.
[53] E. Garrido,et al. Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression , 2016, Oncotarget.
[54] B. Das,et al. Cervical Cancer Stem Cells Selectively Overexpress HPV Oncoprotein E6 that Controls Stemness and Self-Renewal through Upregulation of HES1 , 2016, Clinical Cancer Research.
[55] D. Salomon,et al. Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer , 2016, Breast Cancer Research and Treatment.
[56] Jeong-Seok Nam,et al. CWP232228 targets liver cancer stem cells through Wnt/β-catenin signaling: a novel therapeutic approach for liver cancer treatment , 2016, Oncotarget.
[57] G. Semenza,et al. The hypoxic tumor microenvironment: A driving force for breast cancer progression. , 2016, Biochimica et biophysica acta.
[58] N. Mitsutake,et al. Cancer Stem Cells in the Thyroid , 2016, Front. Endocrinol..
[59] Steven H. Lin,et al. PAF-Wnt signaling-induced cell plasticity is required for maintenance of breast cancer cell stemness , 2016, Nature Communications.
[60] J. Massagué,et al. Metastatic colonization by circulating tumour cells , 2016, Nature.
[61] J. Grandis,et al. Treatment of Triple-Negative Breast Cancer with TORC1/2 Inhibitors Sustains a Drug-Resistant and Notch-Dependent Cancer Stem Cell Population. , 2016, Cancer research.
[62] A. Sette,et al. Cripto-1 vaccination elicits protective immunity against metastatic melanoma , 2016, Oncoimmunology.
[63] M. Jackson,et al. Cancer Stem Cell Plasticity Drives Therapeutic Resistance , 2016, Cancers.
[64] Rajashri R. Parab,et al. Quinomycin A targets Notch signaling pathway in pancreatic cancer stem cells , 2015, Oncotarget.
[65] P. Carmeliet,et al. FOXO1 couples metabolic activity and growth state in the vascular endothelium , 2015, Nature.
[66] M. Khazaei,et al. New Findings on Breast Cancer Stem Cells: A Review , 2015, Journal of breast cancer.
[67] I. Spiteri,et al. Current Challenges in Glioblastoma: Intratumour Heterogeneity, Residual Disease, and Models to Predict Disease Recurrence , 2015, Front. Oncol..
[68] H. Utsumi,et al. Phase 1 study of galunisertib, a TGF-beta receptor I kinase inhibitor, in Japanese patients with advanced solid tumors , 2015, Cancer Chemotherapy and Pharmacology.
[69] R. Salgia,et al. Randomized Phase Ib/II Study of Gemcitabine Plus Placebo or Vismodegib, a Hedgehog Pathway Inhibitor, in Patients With Metastatic Pancreatic Cancer , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[70] F. E. Bertrand,et al. Notch‐1 Promotes Stemness and Epithelial to Mesenchymal Transition in Colorectal Cancer , 2015, Journal of cellular biochemistry.
[71] Yanning Liu,et al. Exosomes derived from miR-122-modified adipose tissue-derived MSCs increase chemosensitivity of hepatocellular carcinoma , 2015, Journal of Hematology & Oncology.
[72] Jie J. Zheng,et al. Structure-based Discovery of Novel Small Molecule Wnt Signaling Inhibitors by Targeting the Cysteine-rich Domain of Frizzled* , 2015, The Journal of Biological Chemistry.
[73] A. Giordano,et al. Targeting CXCR1 on breast cancer stem cells: signaling pathways and clinical application modelling , 2015, Oncotarget.
[74] Xin-hua Liang,et al. Links between cancer stem cells and epithelial–mesenchymal transition , 2015, OncoTargets and therapy.
[75] Jeong-Seok Nam,et al. Combinatorial TGF-β attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cells , 2015, Oncotarget.
[76] S. Shankar,et al. PI3K/AKT/mTOR and sonic hedgehog pathways cooperate together to inhibit human pancreatic cancer stem cell characteristics and tumor growth , 2015, Oncotarget.
[77] W. Liang,et al. Expression of cancer stem cell markers and their correlation with pathogenesis in vascular tumors. , 2015, International journal of clinical and experimental pathology.
[78] K. Bae,et al. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function. , 2015, Gastroenterology.
[79] M. Garg. Emerging role of microRNAs in cancer stem cells: Implications in cancer therapy. , 2015, World journal of stem cells.
[80] Chih-Yang Wang,et al. Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells , 2015, Nature.
[81] I. Weissman,et al. Pre-Clinical Development of a Humanized Anti-CD47 Antibody with Anti-Cancer Therapeutic Potential , 2015, PloS one.
[82] A. Ben-Ze'ev,et al. Clusterin, a gene enriched in intestinal stem cells, is required for L1-mediated colon cancer metastasis , 2015, Oncotarget.
[83] M. Donadelli,et al. The metabolic landscape of cancer stem cells , 2015, IUBMB life.
[84] R. Fodde,et al. IL6/JAK1/STAT3 Signaling Blockade in Endometrial Cancer Affects the ALDHhi/CD126+ Stem-like Component and Reduces Tumor Burden. , 2015, Cancer research.
[85] Paul Workman,et al. Drugging PI3K in cancer: refining targets and therapeutic strategies , 2015, Current opinion in pharmacology.
[86] Michael Kahn,et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update , 2015, Nature Reviews Clinical Oncology.
[87] A. Abrantes,et al. Clinical translation for endometrial cancer stem cells hypothesis , 2015, Cancer and Metastasis Reviews.
[88] S. Scala. Molecular Pathways: Targeting the CXCR4–CXCL12 Axis—Untapped Potential in the Tumor Microenvironment , 2015, Clinical Cancer Research.
[89] D. Scadden,et al. Notch Receptor‐Ligand Engagement Maintains Hematopoietic Stem Cell Quiescence and Niche Retention , 2015, Stem cells.
[90] M. Shah,et al. The BRIGHTER trial: A phase III randomized double-blind study of BBI608 + weekly paclitaxel versus placebo (PBO) + weekly paclitaxel in patients (pts) with pretreated advanced gastric and gastro-esophageal junction (GEJ) adenocarcinoma. , 2015 .
[91] Michael A. Hollingsworth,et al. Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.
[92] E. Turlizzi,et al. Structure-activity relationship and properties optimization of a series of quinazoline-2,4-diones as inhibitors of the canonical Wnt pathway. , 2015, European journal of medicinal chemistry.
[93] E. Morii,et al. Cancer stem-like cells of ovarian clear cell carcinoma are enriched in the ALDH-high population associated with an accelerated scavenging system in reactive oxygen species. , 2015, Gynecologic oncology.
[94] D. Stolz,et al. Identification of a candidate stem cell in human gallbladder. , 2015, Stem cell research.
[95] H. Mackay,et al. A phase II study of single-agent RO4929097, a gamma-secretase inhibitor of Notch signaling, in patients with recurrent platinum-resistant epithelial ovarian cancer: A study of the Princess Margaret, Chicago and California phase II consortia. , 2015, Gynecologic oncology.
[96] S. Digumarthy,et al. Heterogeneity Underlies the Emergence of EGFRT790 Wild-Type Clones Following Treatment of T790M-Positive Cancers with a Third-Generation EGFR Inhibitor. , 2015, Cancer discovery.
[97] Jeong-Seok Nam,et al. Wnt/β-Catenin Small-Molecule Inhibitor CWP232228 Preferentially Inhibits the Growth of Breast Cancer Stem-like Cells. , 2015, Cancer research.
[98] M. Nykter,et al. The Evolutionary History of Lethal Metastatic Prostate Cancer , 2015, Nature.
[99] Z. Werb,et al. The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? , 2015, Cell stem cell.
[100] T. Carey,et al. Cancer stem cells: Mediators of tumorigenesis and metastasis in head and neck squamous cell carcinoma , 2015, Head & neck.
[101] C. Mathers,et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012 , 2015, International journal of cancer.
[102] J. Phillips,et al. Proportional Upregulation of CD97 Isoforms in Glioblastoma and Glioblastoma-Derived Brain Tumor Initiating Cells , 2015, PloS one.
[103] Camille Stephan-Otto Attolini,et al. Stromal gene expression defines poor-prognosis subtypes in colorectal cancer , 2015, Nature Genetics.
[104] F. Rohdich,et al. Discovery of Potent, Orally Bioavailable, Small-Molecule Inhibitors of WNT Signaling from a Cell-Based Pathway Screen , 2015, Journal of medicinal chemistry.
[105] M. Wicha,et al. Notch Reporter Activity in Breast Cancer Cell Lines Identifies a Subset of Cells with Stem Cell Activity , 2015, Molecular Cancer Therapeutics.
[106] A. Jimeno,et al. Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28. , 2015, Pharmacology & therapeutics.
[107] I. López,et al. The inhibitor of differentiation isoform Id1b, generated by alternative splicing, maintains cell quiescence and confers self-renewal and cancer stem cell-like properties. , 2015, Cancer letters.
[108] E. Hurt,et al. Cancer stem cell plasticity and tumor hierarchy. , 2015, World journal of stem cells.
[109] H. A. Rogoff,et al. Suppression of cancer relapse and metastasis by inhibiting cancer stemness , 2015, Proceedings of the National Academy of Sciences.
[110] Qunli Xu,et al. PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells. , 2015, Cancer research.
[111] Mirko H. H. Schmidt,et al. Notching on Cancer’s Door: Notch Signaling in Brain Tumors , 2015, Front. Oncol..
[112] C. Watts,et al. Abrogation of radioresistance in glioblastoma stem‐like cells by inhibition of ATM kinase , 2015, Molecular oncology.
[113] L. Ellis,et al. The requirement for freshly isolated human colorectal cancer (CRC) cells in isolating CRC stem cells , 2014, British Journal of Cancer.
[114] J. Baselga,et al. Pharmacokinetic, pharmacodynamic and biomarker evaluation of transforming growth factor-β receptor I kinase inhibitor, galunisertib, in phase 1 study in patients with advanced cancer , 2014, Investigational New Drugs.
[115] Philip Levy Ho,et al. Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance , 2014, Nature.
[116] V. Zellmer,et al. Evolving concepts of tumor heterogeneity , 2014, Cell & Bioscience.
[117] J. Baselga,et al. First-in-Human Dose Study of the Novel Transforming Growth Factor-β Receptor I Kinase Inhibitor LY2157299 Monohydrate in Patients with Advanced Cancer and Glioma , 2014, Clinical Cancer Research.
[118] Leonid Peshkin,et al. A Noncanonical Frizzled2 Pathway Regulates Epithelial-Mesenchymal Transition and Metastasis , 2014, Cell.
[119] Hua Yu,et al. Revisiting STAT3 signalling in cancer: new and unexpected biological functions , 2014, Nature Reviews Cancer.
[120] You-hong Cui,et al. Metastatic consequences of immune escape from NK cell cytotoxicity by human breast cancer stem cells. , 2014, Cancer research.
[121] S. Hilsenbeck,et al. STAT3 Signaling Is Activated Preferentially in Tumor‐Initiating Cells in Claudin‐Low Models of Human Breast Cancer , 2014, Stem cells.
[122] Edward J. Kim,et al. Pilot Clinical Trial of Hedgehog Pathway Inhibitor GDC-0449 (Vismodegib) in Combination with Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma , 2014, Clinical Cancer Research.
[123] Jingting Jiang,et al. Epithelial-to-mesenchymal transition in human esophageal cancer associates with tumor progression and patient's survival. , 2014, International journal of clinical and experimental pathology.
[124] M. Kahn,et al. Safely targeting cancer stem cells via selective catenin coactivator antagonism , 2014, Cancer science.
[125] C. Swanton,et al. Deciphering intratumor heterogeneity and temporal acquisition of driver events to refine precision medicine , 2014, Genome Biology.
[126] M. Simon,et al. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment. , 2014, Trends in cell biology.
[127] J. Wischhusen,et al. Cancer Stem Cell Immunology: Key to Understanding Tumorigenesis and Tumor Immune Escape? , 2014, Front. Immunol..
[128] R. Weinberg,et al. Tackling the cancer stem cells — what challenges do they pose? , 2014, Nature Reviews Drug Discovery.
[129] M. Mollenhauer,et al. Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine , 2014, Oncotarget.
[130] Miao Sun,et al. Sonic hedgehog signaling may promote invasion and metastasis of oral squamous cell carcinoma by activating MMP-9 and E-cadherin expression , 2014, Medical Oncology.
[131] Ping Li,et al. A radiosensitivity gene signature in predicting glioma prognostic via EMT pathway , 2014, Oncotarget.
[132] A. Calvo,et al. Metastatic dormancy: a complex network between cancer stem cells and their microenvironment. , 2014, Histology and histopathology.
[133] Denis Wirtz,et al. Hypoxia and the extracellular matrix: drivers of tumour metastasis , 2014, Nature Reviews Cancer.
[134] Emma R. Andersson,et al. Therapeutic modulation of Notch signalling — are we there yet? , 2014, Nature Reviews Drug Discovery.
[135] E. Batlle,et al. TGF-beta in CAF-mediated tumor growth and metastasis. , 2014, Seminars in cancer biology.
[136] Keisuke Ito,et al. Metabolic requirements for the maintenance of self-renewing stem cells , 2014, Nature Reviews Molecular Cell Biology.
[137] A. Dubrovska,et al. CXCR4 as biomarker for radioresistant cancer stem cells , 2014, International journal of radiation biology.
[138] T. Oskarsson,et al. Metastatic stem cells: sources, niches, and vital pathways. , 2014, Cell stem cell.
[139] C. Rommel,et al. PI3K and cancer: lessons, challenges and opportunities , 2014, Nature Reviews Drug Discovery.
[140] F. Kopp,et al. Salinomycin treatment reduces metastatic tumor burden by hampering cancer cell migration , 2014, Molecular Cancer.
[141] Sagi Abelson,et al. Niche-Dependent Gene Expression Profile of Intratumoral Heterogeneous Ovarian Cancer Stem Cell Populations , 2013, PloS one.
[142] J. Panyam,et al. CD133-targeted paclitaxel delivery inhibits local tumor recurrence in a mouse model of breast cancer. , 2013, Journal of controlled release : official journal of the Controlled Release Society.
[143] S. Okazaki,et al. Redox regulation in stem-like cancer cells by CD44 variant isoforms , 2013, Oncogene.
[144] M. Fabbri,et al. MicroRNAs and other non-coding RNAs as targets for anticancer drug development , 2013, Nature Reviews Drug Discovery.
[145] Fengfei Wang,et al. Salinomycin: a novel anti-cancer agent with known anti-coccidial activities. , 2013, Current medicinal chemistry.
[146] Keith L Ligon,et al. Delivery of Functional Anti-miR-9 by Mesenchymal Stem Cell–derived Exosomes to Glioblastoma Multiforme Cells Conferred Chemosensitivity , 2013, Molecular therapy. Nucleic acids.
[147] N. McGranahan,et al. The causes and consequences of genetic heterogeneity in cancer evolution , 2013, Nature.
[148] R. Buckanovich,et al. Ovarian cancer stem cells: working towards the root of stemness. , 2013, Cancer letters.
[149] Shree Ram Singh. Gastric cancer stem cells: a novel therapeutic target. , 2013, Cancer letters.
[150] S. Cascinu,et al. Cancer Stem Cell Gene Profile as Predictor of Relapse in High Risk Stage II and Stage III, Radically Resected Colon Cancer Patients , 2013, PloS one.
[151] M. Baumann,et al. Discovery of the cancer stem cell related determinants of radioresistance. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[152] Andrew E. Sloan,et al. Brain Tumor Initiating Cells Adapt to Restricted Nutrition through Preferential Glucose Uptake , 2013, Nature Neuroscience.
[153] Kanghua Li,et al. EMT transcription factors: implication in osteosarcoma , 2013, Medical Oncology.
[154] W. Zimmermann,et al. CXC Chemokine Receptor 4 is Essential for Maintenance of Renal cell Carcinoma‐Initiating Cells and Predicts Metastasis , 2013, Stem cells.
[155] Robert A. Weinberg,et al. Poised Chromatin at the ZEB1 Promoter Enables Breast Cancer Cell Plasticity and Enhances Tumorigenicity , 2013, Cell.
[156] Tom H. Cheung,et al. Molecular regulation of stem cell quiescence , 2013, Nature Reviews Molecular Cell Biology.
[157] H. Hirte,et al. A dose-escalation phase I study of a first-in-class cancer stemness inhibitor in patients with advanced malignancies. , 2013 .
[158] M. Kahn,et al. A phase I first-in-human study of PRI-724 in patients (pts) with advanced solid tumors. , 2013 .
[159] L. Wakefield,et al. Beyond TGFβ: roles of other TGFβ superfamily members in cancer , 2013, Nature Reviews Cancer.
[160] R. Flavell,et al. Human hemato-lymphoid system mice: current use and future potential for medicine. , 2013, Annual review of immunology.
[161] J. Balko,et al. TGF-β inhibition enhances chemotherapy action against triple-negative breast cancer. , 2013, The Journal of clinical investigation.
[162] L. Ailles,et al. Developmental signaling pathways in cancer stem cells of solid tumors. , 2013, Biochimica et biophysica acta.
[163] Cord Naujokat,et al. Salinomycin as a Drug for Targeting Human Cancer Stem Cells , 2012, Journal of biomedicine & biotechnology.
[164] W. de Lau,et al. Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells , 2012, Stem cells.
[165] J. Massagué. TGFβ signalling in context , 2012, Nature Reviews Molecular Cell Biology.
[166] B. Verdoodt,et al. Salinomycin Induces Autophagy in Colon and Breast Cancer Cells with Concomitant Generation of Reactive Oxygen Species , 2012, PloS one.
[167] V. Valero,et al. Epithelial–Mesenchymal Transition and Stem Cell Markers in Patients with HER2-Positive Metastatic Breast Cancer , 2012, Molecular Cancer Therapeutics.
[168] V. Capra,et al. Characterization of Glioma Stem Cells Through Multiple Stem Cell Markers and Their Specific Sensitization to Double‐Strand Break‐Inducing Agents by Pharmacological Inhibition of Ataxia Telangiectasia Mutated Protein , 2012, Brain pathology.
[169] R. Figlin,et al. S1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites. , 2012, Cancer cell.
[170] Jiaoti Huang,et al. The PSA(-/lo) prostate cancer cell population harbors self-renewing long-term tumor-propagating cells that resist castration. , 2012, Cell stem cell.
[171] F. Bertolini,et al. Residual dormant cancer stem-cell foci are responsible for tumor relapse after antiangiogenic metronomic therapy in hepatocellular carcinoma xenografts , 2012, Laboratory Investigation.
[172] P. A. Futreal,et al. Intratumor heterogeneity and branched evolution revealed by multiregion sequencing. , 2012, The New England journal of medicine.
[173] M. Wicha,et al. Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia , 2012, Proceedings of the National Academy of Sciences.
[174] Jens-Peter Volkmer,et al. Three differentiation states risk-stratify bladder cancer into distinct subtypes , 2012, Proceedings of the National Academy of Sciences.
[175] Peter Dirks,et al. Cancer stem cells: an evolving concept , 2012, Nature Reviews Cancer.
[176] Richard J. Jones,et al. Concise Review: Cancer Stem Cells and Minimal Residual Disease , 2012, Stem cells.
[177] M. Hermanová,et al. CD133 Expression and Identification of CD133/nestin Positive Cells in Rhabdomyosarcomas and Rhabdomyosarcoma Cell Lines , 2011, Analytical cellular pathology.
[178] O. Delpuech,et al. FOXO3a regulates reactive oxygen metabolism by inhibiting mitochondrial gene expression , 2011, Cell Death and Differentiation.
[179] Yizheng Wang,et al. The critical role of CD133+CD44+/high tumor cells in hematogenous metastasis of liver cancers , 2011, Cell Research.
[180] R. Ferris,et al. Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells , 2011, Clinical Cancer Research.
[181] Mithat Gönen,et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. , 2011, The Journal of clinical investigation.
[182] R. Qin,et al. CD133(+) gallbladder carcinoma cells exhibit self-renewal ability and tumorigenicity. , 2011, World journal of gastroenterology.
[183] Li-Yan Xu,et al. Tumor Initiating Cells in Esophageal Squamous Cell Carcinomas Express High Levels of CD44 , 2011, PloS one.
[184] P. Bragado,et al. ERK1/2 and p38α/β Signaling in Tumor Cell Quiescence: Opportunities to Control Dormant Residual Disease , 2011, Clinical Cancer Research.
[185] F. Papaccio,et al. Human primary bone sarcomas contain CD133+ cancer stem cells displaying high tumorigenicity in vivo , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[186] Sophia Hsin-Jung Li,et al. Paracrine and Autocrine Signals Induce and Maintain Mesenchymal and Stem Cell States in the Breast , 2011, Cell.
[187] S. Leng,et al. EMT and stem cell-like properties associated with miR-205 and miR-200 epigenetic silencing are early manifestations during carcinogen-induced transformation of human lung epithelial cells. , 2011, Cancer research.
[188] Jørgen Kjems,et al. Coordinated epigenetic repression of the miR‐200 family and miR‐205 in invasive bladder cancer , 2011, International journal of cancer.
[189] M. Ohmura,et al. CD44 variant regulates redox status in cancer cells by stabilizing the xCT subunit of system xc(-) and thereby promotes tumor growth. , 2011, Cancer cell.
[190] D. Hanahan,et al. Hallmarks of Cancer: The Next Generation , 2011, Cell.
[191] C. Münz,et al. Mice with human immune system components as in vivo models for infections with human pathogens , 2011, Immunology and cell biology.
[192] S. Niclou,et al. Critical appraisal of the side population assay in stem cell and cancer stem cell research. , 2011, Cell stem cell.
[193] T. Mak,et al. Regulation of cancer cell metabolism , 2011, Nature Reviews Cancer.
[194] Sungpil Yoon,et al. Salinomycin sensitizes cancer cells to the effects of doxorubicin and etoposide treatment by increasing DNA damage and reducing p21 protein , 2011, British journal of pharmacology.
[195] J. Baselga,et al. TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.
[196] R. Qin,et al. CD44+CD133+ population exhibits cancer stem cell-like characteristics in human gallbladder carcinoma , 2010, Cancer biology & therapy.
[197] C. Bianco,et al. Targeting the embryonic gene Cripto-1 in cancer and beyond , 2010, Expert opinion on therapeutic patents.
[198] Jennifer A. Prescher,et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models , 2010, Proceedings of the National Academy of Sciences.
[199] K. Sugamura,et al. Characterization of the epithelial cell adhesion molecule (EpCAM)+ cell population in hepatocellular carcinoma cell lines , 2010, Cancer science.
[200] K. Mimori,et al. CD13 is a therapeutic target in human liver cancer stem cells. , 2010, The Journal of clinical investigation.
[201] J. Settleman,et al. EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer , 2010, Oncogene.
[202] Hailong Wu,et al. Expression of ABCG2 (BCRP) Is Regulated by Nrf2 in Cancer Cells That Confers Side Population and Chemoresistance Phenotype , 2010, Molecular Cancer Therapeutics.
[203] Eleonora Petrucci,et al. The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor. , 2010, Blood cells, molecules & diseases.
[204] T. Yau,et al. A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. , 2010, Cell stem cell.
[205] B. Vonderhaar,et al. CD44posCD49fhiCD133/2hi defines xenograft-initiating cells in estrogen receptor-negative breast cancer. , 2010, Cancer research.
[206] N. Agarwal,et al. CD117 and Stro-1 identify osteosarcoma tumor-initiating cells associated with metastasis and drug resistance. , 2010, Cancer research.
[207] C. Low,et al. Potential use of the anti-inflammatory drug, sulfasalazine, for targeted therapy of pancreatic cancer. , 2010, Current oncology.
[208] R. McLendon,et al. Integrin alpha 6 regulates glioblastoma stem cells. , 2010, Cell stem cell.
[209] K. Kwon,et al. Nuclear Factor (Erythroid-Derived 2)-Like 2 Regulates Drug Resistance in Pancreatic Cancer Cells , 2010, Pancreas.
[210] D. Greiner,et al. Humanized mouse models to study human diseases , 2010, Current opinion in endocrinology, diabetes, and obesity.
[211] W. Bodmer,et al. Cancer stem cells from colorectal cancer-derived cell lines , 2010, Proceedings of the National Academy of Sciences.
[212] M. O’Connor-McCourt,et al. Transcriptome profiling of a TGF-β-induced epithelial-to-mesenchymal transition reveals extracellular clusterin as a target for therapeutic antibodies , 2010, Oncogene.
[213] G. Tredici,et al. Biological heterogeneity of putative bladder cancer stem‐like cell populations from human bladder transitional cell carcinoma samples , 2010, Cancer science.
[214] D. Birnbaum,et al. CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. , 2010, The Journal of clinical investigation.
[215] L. Yang,et al. Activation of the hedgehog-signaling pathway in human cancer and the clinical implications , 2010, Oncogene.
[216] J. Rich,et al. Hypoxia inducible factors in cancer stem cells , 2010, British Journal of Cancer.
[217] F. Marincola,et al. Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients , 2010, Clinical Cancer Research.
[218] R. McLendon,et al. The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype , 2009, Cell cycle.
[219] F. Esposito,et al. Adaptation to oxidative stress, chemoresistance, and cell survival. , 2009, Antioxidants & redox signaling.
[220] J. Becker,et al. Immunoselection of breast and ovarian cancer cells with trastuzumab and natural killer cells: selective escape of CD44high/CD24low/HER2low breast cancer stem cells. , 2009, Cancer research.
[221] Howard Y. Chang,et al. Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells , 2009, Proceedings of the National Academy of Sciences.
[222] David A Hess,et al. High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability , 2009, Journal of cellular and molecular medicine.
[223] Eric S. Lander,et al. Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening , 2009, Cell.
[224] G. Parmigiani,et al. Differentiation of a Highly Tumorigenic Basal Cell Compartment in Urothelial Carcinoma , 2009, Stem cells.
[225] Jeffrey M. Rosen,et al. The Increasing Complexity of the Cancer Stem Cell Paradigm , 2009, Science.
[226] Marcus Fruttiger,et al. The Notch Ligands Dll4 and Jagged1 Have Opposing Effects on Angiogenesis , 2009, Cell.
[227] L. Cantley,et al. Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation , 2009, Science.
[228] H. Fine,et al. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. , 2009, Cell stem cell.
[229] Zhong Yun,et al. Hypoxic tumor microenvironment and cancer cell differentiation. , 2009, Current molecular medicine.
[230] Irving L. Weissman,et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells , 2009, Nature.
[231] David García-Dorado,et al. TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. , 2009, Cancer cell.
[232] R. Weinberg,et al. Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.
[233] C. Jordan. Cancer stem cells: controversial or just misunderstood? , 2009, Cell stem cell.
[234] Tatsuya Ozawa,et al. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells. , 2009, Cell stem cell.
[235] R. Thompson,et al. CXCR4 mediates the proliferation of glioblastoma progenitor cells. , 2009, Cancer letters.
[236] P. Febbo,et al. Identification of CD15 as a marker for tumor-propagating cells in a mouse model of medulloblastoma. , 2009, Cancer cell.
[237] N. Probst-Hensch,et al. Prognostic Significance of Epithelial-Mesenchymal and Mesenchymal-Epithelial Transition Protein Expression in Non–Small Cell Lung Cancer , 2008, Clinical Cancer Research.
[238] J. Visvader,et al. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions , 2008, Nature Reviews Cancer.
[239] M. Todaro,et al. Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity , 2008, Proceedings of the National Academy of Sciences.
[240] James Briscoe,et al. Pattern formation in the vertebrate neural tube: a sonic hedgehog morphogen-regulated transcriptional network , 2008, Development.
[241] R. McLendon,et al. Targeting cancer stem cells through L1CAM suppresses glioma growth. , 2008, Cancer research.
[242] P. Carter,et al. CD133/prominin-1 is a potential therapeutic target for antibody-drug conjugates in hepatocellular and gastric cancers , 2008, British Journal of Cancer.
[243] G. Goodall,et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1 , 2008, Nature Cell Biology.
[244] S. Fan,et al. Significance of CD90+ cancer stem cells in human liver cancer. , 2008, Cancer cell.
[245] Peter Canoll,et al. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas. , 2008, Neurosurgery.
[246] Mohamed H. Sayegh,et al. Identification of cells initiating human melanomas , 2008, Nature.
[247] J. Chang,et al. Bladder Cancer Initiating Cells (BCICs) Are Among EMA−CD44v6+ Subset: Novel Methods for Isolating Undetermined Cancer Stem (Initiating) Cells , 2008, Cancer investigation.
[248] P. Lichter,et al. Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients , 2008, Clinical Cancer Research.
[249] Shelly C. Lu,et al. Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A–deficient mice , 2007, Hepatology.
[250] J. Lieberman,et al. let-7 Regulates Self Renewal and Tumorigenicity of Breast Cancer Cells , 2007, Cell.
[251] M. Hollingsworth,et al. Cancer metastasis facilitated by developmental pathways: Sonic hedgehog, Notch, and bone morphogenic proteins , 2007, Journal of cellular biochemistry.
[252] J. Aguirre-Ghiso,et al. Models, mechanisms and clinical evidence for cancer dormancy , 2007, Nature Reviews Cancer.
[253] M. Todaro,et al. Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4. , 2007, Cell stem cell.
[254] C. Heeschen,et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. , 2007, Cell stem cell.
[255] Michael F. Clarke,et al. Phenotypic characterization of human colorectal cancer stem cells , 2007, Proceedings of the National Academy of Sciences.
[256] C. Huff,et al. Hedgehog signaling maintains a tumor stem cell compartment in multiple myeloma , 2007, Proceedings of the National Academy of Sciences.
[257] P. Polakis. The many ways of Wnt in cancer. , 2007, Current opinion in genetics & development.
[258] M. Clarke,et al. Identification of pancreatic cancer stem cells. , 2007, Cancer research.
[259] S. Armstrong,et al. FoxOs Are Critical Mediators of Hematopoietic Stem Cell Resistance to Physiologic Oxidative Stress , 2007, Cell.
[260] P. Sánchez,et al. HEDGEHOG-GLI1 Signaling Regulates Human Glioma Growth, Cancer Stem Cell Self-Renewal, and Tumorigenicity , 2007, Current Biology.
[261] L. Ricci-Vitiani,et al. Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.
[262] Mark W. Dewhirst,et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response , 2006, Nature.
[263] A. Giuliano,et al. Most Early Disseminated Cancer Cells Detected in Bone Marrow of Breast Cancer Patients Have a Putative Breast Cancer Stem Cell Phenotype , 2006, Clinical Cancer Research.
[264] T. Golub,et al. Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.
[265] G. Dontu,et al. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. , 2006, Cancer research.
[266] Amar Gajjar,et al. Radial glia cells are candidate stem cells of ependymoma. , 2005, Cancer cell.
[267] Tsz-Kwong Man,et al. Expression profiles of osteosarcoma that can predict response to chemotherapy. , 2005, Cancer research.
[268] T. Fehm,et al. A pooled analysis of bone marrow micrometastasis in breast cancer. , 2005, The New England journal of medicine.
[269] R. Henkelman,et al. Identification of human brain tumour initiating cells , 2004, Nature.
[270] Jonathan W. Uhr,et al. Tumor Cells Circulate in the Peripheral Blood of All Major Carcinomas but not in Healthy Subjects or Patients With Nonmalignant Diseases , 2004, Clinical Cancer Research.
[271] Eric C. Lai,et al. Notch signaling: control of cell communication and cell fate , 2004, Development.
[272] S. Saccani,et al. Regulation of the Chemokine Receptor CXCR4 by Hypoxia , 2003, The Journal of experimental medicine.
[273] S. Morrison,et al. Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[274] I. Weissman,et al. Stem cells, cancer, and cancer stem cells , 2001, Nature.
[275] P. D’Eustachio,et al. Essential role of STAT3 for embryonic stem cell pluripotency. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[276] C. Higgins,et al. The ABC of channel regulation , 1995, Cell.
[277] P. Nowell. The clonal evolution of tumor cell populations. , 1976, Science.
[278] N. Ehlers,et al. Letter: HL-A27 in acute and chronic uveitis. , 1974, Lancet.
[279] S Paget,et al. THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .
[280] M. Arigoni,et al. Immunotargeting of Antigen xCT Attenuates Stem-like Cell Behavior and Metastatic Progression in Breast Cancer. , 2016, Cancer research.
[281] W. Xiaojing,et al. Sonic hedgehog–Gli1 signals promote epithelial–mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway , 2014, Medical Oncology.
[282] Cho Y. Lam,et al. Randomized trial of a presurgical scheduled reduced smoking intervention for patients newly diagnosed with cancer. , 2014, Health psychology : official journal of the Division of Health Psychology, American Psychological Association.
[283] M. Honda,et al. The transcription factor SALL4 regulates stemness of EpCAM-positive hepatocellular carcinoma. , 2014, Journal of hepatology.
[284] M. Herlyn,et al. Intratumoral heterogeneity as a therapy resistance mechanism: role of melanoma subpopulations. , 2012, Advances in pharmacology.
[285] M. Reedijk. Notch signaling and breast cancer. , 2012, Advances in experimental medicine and biology.
[286] M. Cher,et al. Circulating tumor cells: finding the needle in the haystack. , 2011, American journal of cancer research.